[Clitoral hypertrophy as an indicative symptom and its treatment].
D000311:Adrenal Glands / Q000378:metabolism; D013734:Androgen-Insensitivity Syndrome / Q000175:diagnosis; D000728:Androgens / Q000096:biosynthesis / Q000494:pharmacology; D002987:Clitoris / Q000187:drug effects; D003937:Diagnosis, Differential; D012734:Disorders of Sex Development / Q000175:diagnosis; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006066:Gonads / Q000254:growth & development; D006801:Humans; D006889:Hydroxycorticosteroids / Q000627:therapeutic use; D006984:Hypertrophy / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D007231:Infant, Newborn; D008297:Male; D010053:Ovary / Q000378:metabolism; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis; D011247:Pregnancy; D012727:Sex Characteristics
D000728:Androgens; D004967:Estrogens; D006889:Hydroxycorticosteroids
Leitsymptom Klitorishypertrophie und seine Behandlung.